Phan Tung Gia, Takanashi Sayaka, Kaneshi Kunio, Ueda Yuichi, Nakaya Shigekazu, Nishimura Shuichi, Sugita Kumiko, Nishimura Tadashi, Yamamoto Atsuko, Yagyu Fumihiro, Okitsu Shoko, Maneekarn Niwat, Ushijima Hiroshi
Department of Developmental Medical Sciences, Institute of International Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Clin Lab. 2006;52(9-10):519-25.
A total of 752 fecal specimens collected during the period of July 2004 to June 2005 from infants and children with acute gastroenteritis from four different regions (Maizuru, Tokyo, Sapporo, and Osaka) of Japan were tested for the presence of norovirus by RT-PCR. It was found that 139 (18.5%) fecal specimens were positive for norovirus. Norovirus infection was detected almost all year round with the highest prevalence in January. Norovirus GII was the most predominant genogroup (98.6%; 137 of 139). The genotypes detected in this study were GI/1, GII/1, GII/3, GII/4, and GII/6. Of these, NoV GII/4 (known as the Lordsdale virus cluster) was re-emerging and became the leading genotype (77.7%). Meanwhile, the incidence of NoV GII/3 (known as the Arg320 virus cluster) has dropped rapidly, accounting for only 15.8%. Another interesting feature of the study was the identification of Picton03/AU-like recombinant NoV for the first time in Japan. Based on the genetic analysis, it was interesting to note that NoV GII/4 in 2004-2005 made a distinct cluster in comparison to other NoV GII/4 circulating in 2002-2003 and 2003-2004. Of note, "new recombinant variant designated GIIb" within NoV GII/3, which was first detected in Saga City, Japan in 2003-2004 in only one case, had increased, spreading widely in Japan and representing 45.5% (10 of 22). Further epidemiological studies should be conducted to determine whether this new recombinant variant strain will be dominant in Japan in the coming year.
2004年7月至2005年6月期间,从日本四个不同地区(舞鹤、东京、札幌和大阪)患有急性肠胃炎的婴幼儿中总共采集了752份粪便样本,通过逆转录聚合酶链反应(RT-PCR)检测其中是否存在诺如病毒。结果发现,139份(18.5%)粪便样本诺如病毒呈阳性。诺如病毒感染全年几乎都有发现,1月份患病率最高。诺如病毒GII是最主要的基因群(98.6%;139份中的137份)。本研究检测到的基因型有GI/1、GII/1、GII/3、GII/4和GII/6。其中,诺如病毒GII/4(称为洛兹代尔病毒簇)再度出现并成为主要基因型(77.7%)。同时,诺如病毒GII/3(称为Arg320病毒簇)的发病率迅速下降,仅占15.8%。该研究的另一个有趣特征是在日本首次鉴定出皮克顿03/澳大利亚样重组诺如病毒。基于基因分析,值得注意的是,2004 - 2005年的诺如病毒GII/4与2002 - 2003年和2003 - 2004年传播的其他诺如病毒GII/4形成了一个独特的簇。值得注意的是,2003 - 2004年在日本佐贺市仅1例中首次检测到的诺如病毒GII/3内的“新重组变体命名为GIIb”有所增加,在日本广泛传播,占45.5%(22份中的10份)。应开展进一步的流行病学研究,以确定这种新的重组变体菌株在来年是否会在日本占主导地位。